D-chiro-inositol along with myo-inositol decreases the risk of metabolic disease in patients with polycystic ovary syndrome


eMediNexus    11 January 2018

A randomized controlled trial demonstrated that administration of d-chiro-inositol in combination with myo-inositol in 50 overweight females with polycystic ovary syndrome improved the metabolic parameters effectively. The researchers mentioned that this combination is able to reduce the metabolic and clinical alteration of polycystic ovary syndrome and thus can decrease the risk of metabolic disease.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.